The Future of Systemic and Central Nervous System (CNS) Therapies

Our Mission The Solution

Our next-gen medtech is designed to bring hope to millions of people suffering from Alzheimer’s and other neurodegenerative diseases.

ViaNase™ delivers medication nose-to-brain, a direct route past the blood-brain barrier that keeps most drugs out of the brain.

The Solution

30 Million

Chronic sinusitis affects 30 million patients in the U.S. alone.

Central Nervous System disorders are complex, debilitating diseases that affect countless patients across the world, yet there is no cure. It’s difficult to see people we love struggle so much, and it’s even more difficult to find treatment options that are simple, non-invasive, and effective. . . until now.

The Solution

Backed by Research

July, 07 2015Johns Hopkins University · Peer-reviewed · PLoS ONE

Johns Hopkins: Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration

Interested in ViaNase™?

ViaNase™ is available through Kurve’s clinical studies and FDA expanded access (compassionate use). Tell us who you are and we’ll guide you to the right route.